XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies and Concentrations of Risk (Details) - USD ($)
 3 Months Ended 9 Months Ended
Apr. 17, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Significant Accounting Policies and Concentration of Risk [Line Items]            
Restricted cash   $ 1,584,000   $ 1,584,000   $ 1,472,000
Long-term investment maturity, minimum (in years)       12 months    
Inventory adjustments   (170,000)   $ (170,000)    
Inventory valuation reserves   1,347,000   1,347,000   1,177,000
Net proceeds from secured term loans       300,000,000 $ 73,072,000  
Amortization of debt financing costs and original issue discounts   230,000 $ 258,000 $ 1,536,000 $ 597,000  
Antidilutive securities excluded from computation of earnings per share, amount (in shares)       54,772,000 50,430,000  
Reclassification from accumulated other comprehensive income, current period, before tax   $ 0 $ 0 $ 0 $ 0  
Computer Equipment            
Significant Accounting Policies and Concentration of Risk [Line Items]            
Property, plant and equipment, useful life (in years)   3 years   3 years    
Laboratory Equipment, Office Equipment and Software            
Significant Accounting Policies and Concentration of Risk [Line Items]            
Property, plant and equipment, useful life (in years)   5 years   5 years    
Furniture and Fixtures            
Significant Accounting Policies and Concentration of Risk [Line Items]            
Property, plant and equipment, useful life (in years)   7 years   7 years    
Maximum            
Significant Accounting Policies and Concentration of Risk [Line Items]            
Maturity period of high quality marketable securities (in years)       3 years    
Average maturity period of high quality marketable securities (in months)       12 months    
Maturity period of short term investment (in months)       12 months    
Term Loan Tranche A | Pharmakon Advisors, LP | Line of Credit            
Significant Accounting Policies and Concentration of Risk [Line Items]            
Net proceeds from secured term loans $ 300,000     $ 300,000,000    
Collateral for Credit            
Significant Accounting Policies and Concentration of Risk [Line Items]            
Restricted cash   $ 1,466,000   $ 1,466,000   $ 1,449,000